Biotage AB Stock price

Equities

BIOT

SE0000454746

Advanced Medical Equipment & Technology

Real-time Estimate Cboe Europe 06:56:58 2024-03-28 am EDT 5-day change 1st Jan Change
184.1 SEK +1.21% Intraday chart for Biotage AB +6.16% +39.27%
Sales 2023 1.86B 174M Sales 2024 * 2.14B 200M Capitalization 14.67B 1.37B
Net income 2023 246M 22.96M Net income 2024 * 265M 24.74M EV / Sales 2023 5.61 x
Net cash position 2023 335M 31.27M Net cash position 2024 * 488M 45.55M EV / Sales 2024 * 6.64 x
P/E ratio 2023
40.2 x
P/E ratio 2024 *
55.3 x
Employees 674
Yield 2023
1.2%
Yield 2024 *
0.91%
Free-Float 99.55%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.21%
1 week+6.16%
Current month+7.20%
1 month+11.43%
3 months+40.42%
6 months+76.49%
Current year+39.27%
More quotes
1 week
170.40
Extreme 170.4
187.10
1 month
166.60
Extreme 166.6
187.10
Current year
122.20
Extreme 122.2
187.10
1 year
83.05
Extreme 83.05
187.10
3 years
83.05
Extreme 83.05
295.60
5 years
78.05
Extreme 78.05
295.60
10 years
9.80
Extreme 9.8
295.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 72 06-02-08
Director of Finance/CFO - 23-09-24
Chief Tech/Sci/R&D Officer 54 -
Members of the board TitleAgeSince
Chief Executive Officer 72 06-02-08
Director/Board Member 62 19-10-31
Chairman 61 Jan. 03
More insiders
Date Price Change Volume
24-03-28 186 +2.25% 32 827
24-03-27 181.9 -1.20% 187,186
24-03-26 184.1 +3.02% 72,153
24-03-25 178.7 +2.94% 60,532
24-03-22 173.6 -1.03% 43,170

Delayed Quote Nasdaq Stockholm, March 28, 2024 at 06:43 am EDT

More quotes
Biotage AB is a Sweden-based company that develops and sells systems, consumables and services in the field of life sciences. Its customers include pharmaceutical and biotechnology companies, companies within the food industry and academic institutions. The Company offers systems and services within three areas: analytical chemistry, organic chemistry and industrial resins. Biotage's offering within analytical chemistry consists of consumables with related applications to extract selected substances from various types of samples. The Company's offering within organic chemistry includes products for pharmaceutical development based on both small molecules and peptides and its offering within industrial resins is composed of polymer-based resins and research services that lead to the development and manufacture of polymer-based materials. As of December 31, 2013, the Company operated 12 wholly owned subsidiaries worldwide.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
181.9 SEK
Average target price
186.7 SEK
Spread / Average Target
+2.62%
Consensus
  1. Stock
  2. Equities
  3. Stock Biotage AB - Nasdaq Stockholm